Charles Sande/Lancet Infect Dis

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.Terstappen J Hak SF Bhan A Bogaert D Bont LJ Buchholz UJ Clark AD Cohen C Dagan R Feikin DR Graham BS Gupta A Haldar P Jalang'o R Karron RA Kragten L Li Y Lowensteyn YN Munywoki PK Njogu R Osterhaus A Pollard AJ Nazario LR Sande C Satav AR Srikantiah P Stein RT Thacker N Thomas R Bayona MT Mazur NI
Lancet Infect Dis, (2024). 24:e747-e761

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.Mazur NI Terstappen J Baral R Bardaji A Beutels P Buchholz UJ Cohen C Crowe JE, Jr Cutland CL Eckert L Feikin D Fitzpatrick T Fong Y Graham BS Heikkinen T Higgins D Hirve S Klugman KP Kragten-Tabatabaie L Lemey P Libster R Lowensteyn Y Mejias A Munoz FM Munywoki PK Mwananyanda L Nair H Nunes MC Ramilo O Richmond P Ruckwardt TJ Sande C Srikantiah P Thacker N Waldstein KA Weinberger D Wildenbeest J Wiseman D Zar HJ Zambon M Bont L
Lancet Infect Dis, (2023). 23:e2-e21